Tumor infiltrating lymphocytes in squamous cell carcinoma of the head and neck: Mechanisms of enhancement using prostaglandin synthetase inhibitors

Advances in Experimental Medicine and Biology

Volumn 400, Issue B, 1997, Pages 1013-1024

  Cross, David S ^a   Platt, Jeffrey L ^b   Juhn, Steven K ^a   Bach, Fritz H ^b   Adams, George L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CD2 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; AGED; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RESPONSE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE INHIBITORS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNITY, CELLULAR; INDOMETHACIN; LYMPHOCYTES, TUMOR-INFILTRATING; MAJOR HISTOCOMPATIBILITY COMPLEX; T-LYMPHOCYTES, CYTOTOXIC;

BOSCIA;

EID: 0031420250     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (34)

1. 2 production in resting macrophages. Biochem Biophys Res Comm. 136:94-101, 1986.
2. 2-mediated suppression of cellular immunity in colon cancer patients. Surgery 95:71-76, 1984.
3. Berlinger, N.T. Deficient immunity in head and neck cancer due to excessive monocyte production of prostaglandins. Laryngoscope 94:1407-1410, 1984.
4. Blitzer, A. and Huang, C.C. The effect of indomethacin on the growth of epidermoid carcinomas of the palate in rats. Arch Otolaryngol. 109:719-723, 1983.
5. Boscia, R., Johnson, J.T., Chen, K. and Whiteside, T.L. Evaluation of therapeutic potential of interleukin-2 expanded tumor infiltrating lymphocytes in squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 99:414-421, 1988.
6. Bretscher, P. and Cohn, M.A. theory of self-nonself discrimination. Science. 169:1042-1049, 1970.
7. Chouaib, S. and Fradelizi, D. The mechanism of inhibition of human IL2 production. J Immunol. 129:2463-2468, 1982.
8. 2 induction of suppressor lymphocytes. J Immunol. 132:1851-7, 1984.
9. Cross, D.S. Tumor associated prostaglandins and host immune response in squamous cell carcinoma of the head and neck. 1992a; Ph.D. Thesis, University of Minnesota.
10. Cross, D.S., Platt, J.L., Juhn, S.K., Bach, F.H. and Adams, G.L. Administration of a prostaglandin synthesis inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 118:526-8, 1992b.
11. Eckels, D.D. and Gershwin, M.E. Pharmocologic and biochemical modulation of human T-lymphocyte colony formation: hormonal influences. Immunopharmacol. 3:259-74, 1981.
12. Favelli, C., Garaci, E., Etheredge, E., Santoro, M.G. and Jaffe, B.M. Influence of PGE on the immune response in melanoma bearing mice. J Immunol. 125:897-902, 1980.
13. 2 in the induction of nonspecific T lymphocyte suppressor activity. 126:1452-55, 1981.
14. Gilbert, K.M., Hoang, K.D. and Weigle, W.O. Th1 and Th2 clones differ in their response to a tolerogenic signal. J Immunol. 144:2063-2071, 1990.
15. Guo, M., Rabin, B.S., Johnson, J.T. and Paradis, I.L. Lymphocyte phenotypes at tumor margins in patients with head and neck cancer. Head Neck Surgery 265-271, 1987.
16. Hial, V., Horakova, Z., Schaff, R.E. and Beaven, M.A. Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mice. Euro J Pharm. 37:367-376, 1976.
17. Houck, J.R., Sexton, F.M. and Zajdel, G. HLA class I and class II antigen expression on squamous cell carcinoma of the head and neck. 116:1181-5, 1990.
18. Jenkins, M.K. The role of cell division in the induction of clonal anergy. Immunology Today. 13:69-73, 1992.
19. Koch, W.M., Dugan, E., Diaz, L.A. and Richtsmeier, W.J. Induction of HLA-DR antigen on human squamous cell carcinoma by recombinant interferon gamma. Laryngoscope. 98:511-515, 1988.
20. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem. 263:5380-5384, 1988.
21. 2. Bioch Bioph Res Comm. 137:404-410, 1986a.
22. Kunkel, S.L., Chensue, S.W. and Phan, S.H. Prostaglandins as endogenous mediators of interleukin-1 production. J Immunol. 136:186-192, 1986b.
23. Lamb, J.R., Skidmore, B.J., Green, N., Chiller, J.M. and Feldman, M. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic hemagglutinen. J Exp Med. 157:1434-1447, 1983.
24. Lotze, M.T. and Finn, O.J. Recent advances in cellular immunology: implications for immunity to cancer. Immunology Today. 190-193, 1990.
25. Markman, J., Lo, D., Naji, A., Palmiter, R.D., Brinster, R.L. and Heber-Katz, E. Antigen presenting function of class II MHC expressing pancreatic beta cells. Nature 336:476-9, 1988.
26. McKinnon, J.G., Hoover, S.K., Inge, T.H. and Bear, H.D. Activation and expansion of cytotoxic T lymphocytes from tumor-draining lymph nodes. 32:38-44, 1990.
27. Mueller, D.L., Jenkins, M.K. and Schwartz, R.H. Clonal expansion versus functional clonal inactivation. Ann Rev Immunol. 7:445-80, 1989.
28. Nossal, G.J.V. Cellular mechanisms of immunological tolerance. Ann Rev Immunol. 1:33-62, 1983.
29. Panje, W.R. Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. Arch Otolaryngol. 107:658-663, 1981.
30. Piacibello, W., Rubin, B.Y. and Broxmeyer, H.E. Prostaglandin E counteracts the gamma interferon induction of major histocompatibility complex class II antigens on U937 cells and induction of responsiveness of U937 colony forming cells to suppression by lactoferrin, transferrin, acidic isoferritins and prostaglandin E. Exp Hematol. 14:44-50, 1986.
31. 2 effects on human suppressor cell function and on interleukin 2 function. J Immunol. 129:2469-73, 1982.
32. Weaver, C.T. and Unanue, E.R. Immunology Today. 11:49-55, 1990.
33. Wolf, G.T., Hudson, J.L., Peterson, K.A., Miller, H.L. and McClatchey, K.D. Lymphocyte subpopulations infiltrating squamous carcinomas of head and neck: correlations with extent of tumor and prognosis. Otolaryngol Head Neck Surg. 95:142-152, 1986.
34. Wolf, G.T., Schmaltz, S., Hudson, J., et al. Alterations in T lymphocyte subpopulations in patients with head and neck squamous cell carcinoma: correlation with prognosis. Arch Otolaryngol Head Neck Surg. 113:1200-1206, 1987.